Roger Newman to Cost-Benefit Analysis
This is a "connection" page, showing publications Roger Newman has written about Cost-Benefit Analysis.
Connection Strength
0.028
-
Cost-effectiveness of maternal treatment to prevent perinatal hepatitis B virus transmission. Obstet Gynecol. 2011 Sep; 118(3):655-662.
Score: 0.020
-
Cost-effective delivery management of the vertex and nonvertex twin gestation. Am J Obstet Gynecol. 1998 Oct; 179(4):864-9.
Score: 0.008